Company / CapEx per Share
Avalo Therapeutics, Inc. CapEx per Share History
FY2017-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2022
5-year range
$0.00 / $0.01
FY2018-FY2022
Trend
+570.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +571% YoY in FY2022, a notable deviation from the 5-year average annual change of +213%.
Based on SEC 10-K filings.
0.01 in FY2022 with a 5-year CAGR of +32.5%.
Improved from $0.00 to $0.01 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +16.3%
- 5-Year CAGR
- +32.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, capex per share increased 570.8% year-over-year.
- Peak capex per share was recorded in FY2018.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.01 | +570.8% |
| FY2021 | $0.00 | +6.1% |
| FY2020 | $0.00 | -77.9% |
| FY2019 | $0.01 | -64.4% |
| FY2018 | $0.02 | +630.1% |
| FY2017 | $0.00 | - |
As of FY2022 · SEC Form 10-K · Last checked Jun 21, 2026